Improvement of surgical results for pancreatic cancer
- 1 October 2013
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 14 (11), e476-e485
- https://doi.org/10.1016/s1470-2045(13)70172-4
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk IndividualsGastroenterology, 2012
- Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intentCancer, 2011
- Trends in Hospital Volume and Operative Mortality for High-Risk SurgeryThe New England Journal of Medicine, 2011
- Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinomaCancer, 2010
- Variation in Hospital Mortality Associated with Inpatient SurgeryThe New England Journal of Medicine, 2009
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic CancerBritish Journal of Cancer, 2009
- Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trialsBritish Journal of Cancer, 2009
- Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO studyAnnals of Oncology, 2008
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007
- Hospital Volume and Late Survival After Cancer SurgeryAnnals of Surgery, 2007